The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Research Report 2025
Synopsis
A contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.
The global Bio Contract Development and Manufacturing Organizations (CDMOs) market was valued at US$ 21630 million in 2023 and is anticipated to reach US$ 41780 million by 2030, witnessing a CAGR of 10.0% during the forecast period 2024-2030.
North American market for Bio Contract Development and Manufacturing Organizations (CDMOs) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bio Contract Development and Manufacturing Organizations (CDMOs) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Bio Contract Development and Manufacturing Organizations (CDMOs) in Pharmaceutical Company is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Bio Contract Development and Manufacturing Organizations (CDMOs) include Lonza, Boehringer Ingelheim, Celltrion, Fujifilm, Selexis, Ology Bio, Ardena, Catalent and AGC, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bio Contract Development and Manufacturing Organizations (CDMOs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio Contract Development and Manufacturing Organizations (CDMOs).
Report Scope
The Bio Contract Development and Manufacturing Organizations (CDMOs) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bio Contract Development and Manufacturing Organizations (CDMOs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio Contract Development and Manufacturing Organizations (CDMOs) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Boehringer Ingelheim
Celltrion
Fujifilm
Selexis
Ology Bio
Ardena
Catalent
AGC
Amgen
Segment by Type
API Development
Manufacturing
Drug Delivery
Segment by Application
Pharmaceutical Company
Biotechnology Company
Generic Company
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bio Contract Development and Manufacturing Organizations (CDMOs) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.
The global Bio Contract Development and Manufacturing Organizations (CDMOs) market was valued at US$ 21630 million in 2023 and is anticipated to reach US$ 41780 million by 2030, witnessing a CAGR of 10.0% during the forecast period 2024-2030.
North American market for Bio Contract Development and Manufacturing Organizations (CDMOs) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bio Contract Development and Manufacturing Organizations (CDMOs) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Bio Contract Development and Manufacturing Organizations (CDMOs) in Pharmaceutical Company is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Bio Contract Development and Manufacturing Organizations (CDMOs) include Lonza, Boehringer Ingelheim, Celltrion, Fujifilm, Selexis, Ology Bio, Ardena, Catalent and AGC, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bio Contract Development and Manufacturing Organizations (CDMOs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio Contract Development and Manufacturing Organizations (CDMOs).
Report Scope
The Bio Contract Development and Manufacturing Organizations (CDMOs) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bio Contract Development and Manufacturing Organizations (CDMOs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio Contract Development and Manufacturing Organizations (CDMOs) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Boehringer Ingelheim
Celltrion
Fujifilm
Selexis
Ology Bio
Ardena
Catalent
AGC
Amgen
Segment by Type
API Development
Manufacturing
Drug Delivery
Segment by Application
Pharmaceutical Company
Biotechnology Company
Generic Company
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bio Contract Development and Manufacturing Organizations (CDMOs) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 API Development
1.2.3 Manufacturing
1.2.4 Drug Delivery
1.3 Market by Application
1.3.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Generic Company
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Perspective (2019-2030)
2.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Growth Trends by Region
2.2.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Historic Market Size by Region (2019-2024)
2.2.3 Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Region (2025-2030)
2.3 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Dynamics
2.3.1 Bio Contract Development and Manufacturing Organizations (CDMOs) Industry Trends
2.3.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Drivers
2.3.3 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Challenges
2.3.4 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bio Contract Development and Manufacturing Organizations (CDMOs) Players by Revenue
3.1.1 Global Top Bio Contract Development and Manufacturing Organizations (CDMOs) Players by Revenue (2019-2024)
3.1.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Players (2019-2024)
3.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue
3.4 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Concentration Ratio
3.4.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue in 2023
3.5 Bio Contract Development and Manufacturing Organizations (CDMOs) Key Players Head office and Area Served
3.6 Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Product Solution and Service
3.7 Date of Enter into Bio Contract Development and Manufacturing Organizations (CDMOs) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bio Contract Development and Manufacturing Organizations (CDMOs) Breakdown Data by Type
4.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Historic Market Size by Type (2019-2024)
4.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Type (2025-2030)
5 Bio Contract Development and Manufacturing Organizations (CDMOs) Breakdown Data by Application
5.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Historic Market Size by Application (2019-2024)
5.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2019-2030)
6.2 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2019-2024)
6.4 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2019-2030)
7.2 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2019-2024)
7.4 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2019-2030)
8.2 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Region (2019-2024)
8.4 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2019-2030)
9.2 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2019-2024)
9.4 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2019-2030)
10.2 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2019-2024)
10.4 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.1.4 Lonza Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.2.4 Boehringer Ingelheim Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2019-2024)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Celltrion
11.3.1 Celltrion Company Detail
11.3.2 Celltrion Business Overview
11.3.3 Celltrion Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.3.4 Celltrion Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2019-2024)
11.3.5 Celltrion Recent Development
11.4 Fujifilm
11.4.1 Fujifilm Company Detail
11.4.2 Fujifilm Business Overview
11.4.3 Fujifilm Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.4.4 Fujifilm Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2019-2024)
11.4.5 Fujifilm Recent Development
11.5 Selexis
11.5.1 Selexis Company Detail
11.5.2 Selexis Business Overview
11.5.3 Selexis Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.5.4 Selexis Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2019-2024)
11.5.5 Selexis Recent Development
11.6 Ology Bio
11.6.1 Ology Bio Company Detail
11.6.2 Ology Bio Business Overview
11.6.3 Ology Bio Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.6.4 Ology Bio Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2019-2024)
11.6.5 Ology Bio Recent Development
11.7 Ardena
11.7.1 Ardena Company Detail
11.7.2 Ardena Business Overview
11.7.3 Ardena Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.7.4 Ardena Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2019-2024)
11.7.5 Ardena Recent Development
11.8 Catalent
11.8.1 Catalent Company Detail
11.8.2 Catalent Business Overview
11.8.3 Catalent Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.8.4 Catalent Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2019-2024)
11.8.5 Catalent Recent Development
11.9 AGC
11.9.1 AGC Company Detail
11.9.2 AGC Business Overview
11.9.3 AGC Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.9.4 AGC Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2019-2024)
11.9.5 AGC Recent Development
11.10 Amgen
11.10.1 Amgen Company Detail
11.10.2 Amgen Business Overview
11.10.3 Amgen Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.10.4 Amgen Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2019-2024)
11.10.5 Amgen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
